{"id":"W4316086203","doi":"10.14309/01.ajg.0000860116.18323.9e","title":"S869 Real World Clinical Effectiveness and Safety of Vedolizumab and Adalimumab in Biologic-Naïve Patients With Crohn’s Disease: Results From the EVOLVE Study","year":2022,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thermo Fisher Scientific (Canada); University of British Columbia","funders":"","keywords":"Medicine; Vedolizumab; Adalimumab; Internal medicine; Hazard ratio; Discontinuation; Crohn's disease; Infliximab; Retrospective cohort study; Surgery; Gastroenterology; Oncology; Disease; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005655195,0.0002721219,0.001079013,0.0003974123,0.0002358406,0.0009809261,0.0003163003,0.0004935803,0.001225707],"category_scores_gemma":[0.006181813,0.0001475205,0.001823078,0.000675754,0.000331344,0.0005106109,0.0004972722,0.0004618611,0.0002444725],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007358214,"about_ca_system_score_gemma":0.0007480512,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001730085,"about_ca_topic_score_gemma":0.002917468,"domain_scores_codex":[0.9971405,0.001497895,0.000334458,0.0002772432,0.0006280025,0.0001218974],"domain_scores_gemma":[0.9932939,0.0023969,0.002617533,0.0004471177,0.0006699623,0.0005745841],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08958969,0.001744017,0.8481628,0.0006809172,0.005452361,0.0001592998,0.0002594291,0.0009692591,0.0009926518,0.0001470135,0.00130663,0.05053588],"study_design_scores_gemma":[0.01094245,0.01806567,0.9623605,0.0001892366,0.002803637,0.0004370191,0.0001953335,0.001232525,0.0006742029,0.0001085605,0.002948778,0.00004200417],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956233,0.002215902,0.00007756332,0.0001003925,0.00001469051,0.0000661646,0.001205205,0.000004664841,0.0006920676],"genre_scores_gemma":[0.9955902,0.0007430285,0.0002729268,0.0001329818,0.00006305541,0.00006506799,0.002910948,0.000003618183,0.0002181444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005655195,"threshold_uncertainty_score":0.02990788,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007534759067232864,"score_gpt":0.2593088850461118,"score_spread":0.2517741259788789,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}